SG11202003437PA - Calcium release-activated calcium channel modulators for treating hematological and solid cancers - Google Patents
Calcium release-activated calcium channel modulators for treating hematological and solid cancersInfo
- Publication number
- SG11202003437PA SG11202003437PA SG11202003437PA SG11202003437PA SG11202003437PA SG 11202003437P A SG11202003437P A SG 11202003437PA SG 11202003437P A SG11202003437P A SG 11202003437PA SG 11202003437P A SG11202003437P A SG 11202003437PA SG 11202003437P A SG11202003437P A SG 11202003437PA
- Authority
- SG
- Singapore
- Prior art keywords
- channel modulators
- solid cancers
- treating hematological
- calcium
- activated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201741038447 | 2017-10-30 | ||
| PCT/IB2018/058461 WO2019087047A1 (en) | 2017-10-30 | 2018-10-29 | Calcium release-activated calcium channel modulators for treating hematological and solid cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202003437PA true SG11202003437PA (en) | 2020-05-28 |
Family
ID=64426982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202003437PA SG11202003437PA (en) | 2017-10-30 | 2018-10-29 | Calcium release-activated calcium channel modulators for treating hematological and solid cancers |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200281918A1 (ko) |
| EP (1) | EP3703693A1 (ko) |
| JP (1) | JP2021501160A (ko) |
| KR (1) | KR20200079256A (ko) |
| CN (1) | CN111629727A (ko) |
| AU (1) | AU2018360367A1 (ko) |
| BR (1) | BR112020008219A2 (ko) |
| CA (1) | CA3079143A1 (ko) |
| EA (1) | EA202090682A1 (ko) |
| IL (1) | IL274044A (ko) |
| SG (1) | SG11202003437PA (ko) |
| WO (1) | WO2019087047A1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113712945B (zh) * | 2021-09-18 | 2022-08-02 | 中国人民解放军陆军军医大学第二附属医院 | 4-氯-3-乙基苯酚在制备肿瘤化疗药物增敏剂中的应用及抗肿瘤组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU610083B2 (en) | 1986-08-18 | 1991-05-16 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
| WO2007081804A2 (en) | 2006-01-05 | 2007-07-19 | Immune Disease Institute, Inc. | Regulators of nfat |
| US8993612B2 (en) | 2009-10-08 | 2015-03-31 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| US8377970B2 (en) * | 2009-10-08 | 2013-02-19 | Rhizen Pharmaceuticals Sa | Modulators of calcium release-activated calcium channel |
| WO2016115054A2 (en) * | 2015-01-13 | 2016-07-21 | Vivreon Biosciences, Llc | Modulators of ca2+ release-activated ca2+ (crac) channels and pharmaceutical uses thereof |
-
2018
- 2018-10-29 JP JP2020523729A patent/JP2021501160A/ja active Pending
- 2018-10-29 EP EP18807415.7A patent/EP3703693A1/en not_active Withdrawn
- 2018-10-29 CA CA3079143A patent/CA3079143A1/en not_active Abandoned
- 2018-10-29 AU AU2018360367A patent/AU2018360367A1/en not_active Abandoned
- 2018-10-29 CN CN201880069971.8A patent/CN111629727A/zh active Pending
- 2018-10-29 SG SG11202003437PA patent/SG11202003437PA/en unknown
- 2018-10-29 KR KR1020207012595A patent/KR20200079256A/ko unknown
- 2018-10-29 US US16/759,629 patent/US20200281918A1/en not_active Abandoned
- 2018-10-29 WO PCT/IB2018/058461 patent/WO2019087047A1/en unknown
- 2018-10-29 EA EA202090682A patent/EA202090682A1/ru unknown
- 2018-10-29 BR BR112020008219-8A patent/BR112020008219A2/pt not_active Application Discontinuation
-
2020
- 2020-04-19 IL IL274044A patent/IL274044A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3703693A1 (en) | 2020-09-09 |
| KR20200079256A (ko) | 2020-07-02 |
| JP2021501160A (ja) | 2021-01-14 |
| CA3079143A1 (en) | 2019-05-09 |
| US20200281918A1 (en) | 2020-09-10 |
| BR112020008219A2 (pt) | 2020-10-27 |
| AU2018360367A1 (en) | 2020-05-28 |
| IL274044A (en) | 2020-06-30 |
| CN111629727A (zh) | 2020-09-04 |
| WO2019087047A1 (en) | 2019-05-09 |
| EA202090682A1 (ru) | 2020-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202011080QA (en) | Methods and compositions for treating cancer | |
| IL269150A (en) | Preparations and methods for the treatment of cancer | |
| IL263224A (en) | Methods and preparations for the treatment of cancer | |
| PL3431105T3 (pl) | Kompozycja lecznicza do leczenia raka | |
| IL274837A (en) | Methods and preparations for the treatment of cancer | |
| SG11202003185RA (en) | Methods and apparatuses for frequency division multiplexing for mixed numerology | |
| IL269157A (en) | Preparations and methods for the treatment of cancer | |
| SG10202109912XA (en) | Methods and compositions for treating cancers using antisense | |
| IL271019A (en) | Tinostemustine for the treatment of ovarian cysts | |
| SG11202012435UA (en) | Compositions and methods for treating cancer | |
| IL261146A (en) | Methods and compounds for the treatment of cancerous tumors and malignancies | |
| IL282478A (en) | Materials and methods for cancer treatment | |
| ZA201900939B (en) | Combination treatment for hematological cancers | |
| EP3429613A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANCER | |
| IL261010B (en) | Compositions and methods for treating chronic wounds | |
| IL271923A (en) | Methods and compositions for treating addictions | |
| ZA201904932B (en) | Techniques and apparatuses for channel interference reduction | |
| IL274044A (en) | Calcium release activated calcium channel blockers for the treatment of hematological and solid cancers | |
| IL272782A (en) | Preparations and methods for the treatment of cancer | |
| IL273155A (en) | Methods for treating depression and major depressive disorders | |
| IL269769B (en) | Mixtures, composition and their use for cancer treatment | |
| LT3630112T (lt) | Regorafenibo ir nivolumabo derinys, skirtas vėžio gydymui | |
| EP3572080A4 (en) | COMPOSITION INTENDED TO INHIBIT CANCER METASTASIS AND TREAT CANCER | |
| SG11202104692VA (en) | Compositions and methods for treating cancer | |
| IL255541A (en) | Cabazitaxel and its use for treating cancer |